extensive stage small cell lung cancer (SCLC) research hub

Durvalumab (MEDI4736) in combination with consolidative radiochemotherapy and ablative stereotactic radiotherapy in extensive stage SCLC

This study is looking at a new way to treat an advanced type of lung cancer called extensive stage small cell lung cancer. It combines standard treatments like chemotherapy and radiotherapy with a new drug called Durvalumab (Imfinzi) to see if it can stop the cancer from growing for longer.